A team, a shared passion
Founder, President & CEO
Yves Henrotin is Founder, Chairman of the board, and President at Artialis. He is Professor of Pathology, Physical Therapy and Rehabilitation and Director of the Bone and Cartilage Research Unit at the University of Liège (Belgium). He is also head of the Physical Therapy and Rehabilitation department at the Princess Paola Hospital, Belgium. He is a member of the American College of Rheumatology, the Osteoarthritis Research Society International, the French Society of Rheumatology and the International Cartilage Repair Society.
Chief Financial Officer
Ali Baladi is Chief Financial Officer at Artialis. Ali Baladi brings 18 years’ experience in the pharmaceutical industry in a variety of country and regional management positions across Europe and Asia. Ali joined Pfizer Inc. in 1999. He progressed through finance (1999-2009), operations (2010-2011), and Commercial leadership roles (2012-2016). Ali was appointed to the position of Vice President-Vaccines cluster Lead Europe in January 2014 where he was leading the vaccines business across 48 countries in Europe and Central Asia.
Myriam Gharbi is Value Stream Director at Artialis. She is responsible for creating value for the Company and its customers.
Prior to joining Artialis, she worked at the Bone and Cartilage Research Unit of Prof Yves Henrotin in the field of biomarkers discovery and development. She obtained her PhD in 2006 in Pharmaceutical and Biomedical Sciences in the Department of Biochemistry and General Physiology University of Liège.
Anne Cornet is R&D Director at Artialis. She is responsible for development of new biomarkers and technologies at Artialis.
Prior to joining Artialis, she worked on influenza virus at the Veterinary College of ULg. She prepared and obtained her PhD at the laboratory of human biochemistry and worked on various R&D projects in proteomic and molecular biology.
Bérénice Costes is Director of Clinical Operations at Artialis. She is managing and supervising clinical trials on medical devices, dietary supplements, and medicine. She holds a PhD in sciences from ULg and was a post-doctoral researcher of the FNRS. She also received training in Project Management and Clinical Research. She worked as Project Manager for the development of IVD kit and Pharmaceutical product for Uteron Pharma.
Christelle Boileau is Director of Preclinical Operations at Artialis. Christelle specializes in Preclinical Studies Management and brings fifteen years of experience to Artialis. She holds a PhD in Pharmacology and completed a post-doctoral fellowship in Biomedical Science. She built her expertise in preclinical models applied to rheumatology in Henri Poincaré University in Nancy, France and at the University of Montreal, Québec.
Administration and Accounting
Jeannette Chignesse is Administrative and Accounting Officer at Artialis.
Prior to joining Artialis, she worked in Luxembourg as an Asset Manager at Fiducenter S.A, a company specialized in wealth management for professionals and companies. She obtained a degree of Management Assistant by HELMO Saint-Martin in June 2011.